M ounjaro is the brand name for tirzepatide, a prescription medication developed by Eli Lilly that is primarily used to treat type 2 diabetes in adults. It is a once-weekly inject ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

The Outsourcing Facilities Association filed lawsuits against the FDA about the “sudden removal” of tirzepatide and semaglutide from the drug shortage list, but the judge in both cases ruled ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Another published last year in JAMA Internal Medicine had similar results, with tirzepatide leading to more weight loss than semaglutide, which is the active ingredient ... s list of drug ...